Oncothyreon Inc. (Nasdaq: ONTY) and Celldex Therapeutics, Inc., (Nasdaq: CLDX) announced that they have agreed to collaborate on a combined ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE